Cargando…
Omega-3 Index and Cardiovascular Health
Recent large trials with eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in the cardiovascular field did not demonstrate a beneficial effect in terms of reductions of clinical endpoints like total mortality, sudden cardiac arrest or other major adverse cardiac events. Pertinent guidelines...
Autor principal: | von Schacky, Clemens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3942733/ https://www.ncbi.nlm.nih.gov/pubmed/24566438 http://dx.doi.org/10.3390/nu6020799 |
Ejemplares similares
-
Omega-3 Fatty Acids in Pregnancy—The Case for a Target Omega-3 Index
por: von Schacky, Clemens
Publicado: (2020) -
Omega-3 Index and Sudden Cardiac Death
por: von Schacky, Clemens
Publicado: (2010) -
A Review of Omega-3 Ethyl Esters for Cardiovascular Prevention and Treatment of Increased Blood Triglyceride Levels
por: von Schacky, Clemens
Publicado: (2006) -
Data on gender and subgroup specific analyses of omega-3 fatty acids in the Ludwigshafen Risk and Cardiovascular Health Study
por: Kleber, Marcus E., et al.
Publicado: (2016) -
Discrepancy between Knowledge and Perceptions of Dietary Omega-3 Fatty Acid Intake Compared with the Omega-3 Index
por: Thuppal, Sowmyanarayanan V., et al.
Publicado: (2017)